Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05042102 · ClinicalTrials.gov registry record · Phase 2
Donepezil and Cognitive Training for Alcohol Use Disorder (AUD)
A Phase 2 study of Alcohol Use Disorder, sponsored by VA Connecticut Healthcare System.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 160
- Enrollment target
- 1
- Study location
NCT05042102 is a Phase 2 study of Alcohol Use Disorder that is actively recruiting participants, run by VA Connecticut Healthcare System. The registered enrollment target is 160 participants, below the 328-participant average among 184 other Alcohol Use Disorder trials with a reported enrollment target (51% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05042102, a Phase 2 study of Alcohol Use Disorder, is actively recruiting participants, sponsored by VA Connecticut Healthcare System.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 160 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of the project is to evaluate whether donepezil + cognitive remediation therapy is superior to placebo in reducing heavy drinking in patients with alcohol use disorder in a double-blind, placebo-controlled trial.
Conditions Studied
Interventions
- COMBINATION_PRODUCT Donepezil + Cognitive remediation therapy (CRT)
- COMBINATION_PRODUCT Donepezil + Placebo CRT
- COMBINATION_PRODUCT Placebo medication + Cognitive remediation therapy (CRT)
- COMBINATION_PRODUCT Placebo medication + Placebo CRT
Study Locations (1)
Connecticut
- VA Connecticut Healthcare System - West Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2022-08-08 |
| Est. Completion | 2027-05-31 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05042102
The ClinicalTrials.gov registry entry for NCT05042102 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 160 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 328-participant average among 184 other Alcohol Use Disorder trials with a reported enrollment target (51% lower). The listed sponsor is VA Connecticut Healthcare System, which has 26 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Alcohol Use Disorder appearing as the primary indexed condition, and to 4 interventions - of which Donepezil + Cognitive remediation therapy (CRT) is the first listed.
NCT05042102 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.
Frequently Asked Questions
What is clinical trial NCT05042102 about?
NCT05042102 is a clinical study titled "Donepezil and Cognitive Training for Alcohol Use Disorder (AUD)". The goal of the project is to evaluate whether donepezil + cognitive remediation therapy is superior to placebo in reducing heavy drinking in patients with alcohol use disorder in a double-blind, placebo-controlled trial.
What is the current status of trial NCT05042102?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 160 participants. The study started on 2022-08-08. Estimated completion is 2027-05-31.
What conditions does trial NCT05042102 study?
This clinical trial studies the following conditions: Alcohol Use Disorder.
What interventions are being tested in trial NCT05042102?
The interventions under investigation include: Donepezil + Cognitive remediation therapy (CRT) (COMBINATION_PRODUCT), Donepezil + Placebo CRT (COMBINATION_PRODUCT), Placebo medication + Cognitive remediation therapy (CRT) (COMBINATION_PRODUCT), Placebo medication + Placebo CRT (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT05042102?
This trial is sponsored by VA Connecticut Healthcare System, which has 26 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05042102 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alcohol Use Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Orexin Receptor Antagonism for the Treatment of Alcohol Use Disorder and Stress-Related Drinking
RECRUITING · Phase 2
-
Enhanced Digital-Chemosensory-Based Olfactory Training for Remote Management of Substance Use Disorders
RECRUITING · Phase 2
-
Psilocybin or Ketamine for Alcohol Use Disorder: An Active Comparator Trial
RECRUITING · Phase 2
-
Cannabis' Impact on Alcohol Consumption
RECRUITING · Phase 2
-
COMT Inhibition Among Individuals With Comorbid AUD/ADHD
RECRUITING · Phase 2
-
Semaglutide Therapy for Alcohol Reduction (STAR)
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.